META Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Meta Platforms Inc is not a strong buy for a long-term, beginner investor at this moment. While the company's financial performance and AI advancements are promising, the stock appears overbought based on technical indicators, and there are mixed analyst ratings with lowered price targets. Additionally, geopolitical and macroeconomic uncertainties could weigh on consumer spending and ad revenue growth. Given the user's impatience and unwillingness to wait for optimal entry points, it is better to hold off on investing in META right now.
The MACD is positive and expanding, indicating bullish momentum. However, the RSI is at 87.06, signaling that the stock is overbought. The stock is trading near resistance levels (R1: 666.071, R2: 694.107), suggesting limited immediate upside potential. The moving averages are converging, indicating a lack of a strong trend direction.
Meta's launch of Muse Spark, a large language model, has been positively received and is expected to enhance its AI capabilities. The company's strong Q4 2025 financial performance, with a 23.78% YoY revenue increase and a 9.26% YoY net income growth, reflects solid operational execution. Analysts like JPMorgan and KeyBanc highlight Meta's AI-driven growth potential and platform stickiness.
Analysts have lowered price targets due to macroeconomic concerns, including the impact of the Iran war on consumer spending. The RSI indicates the stock is overbought, and there is a 60% chance of a short-term price decline. Elevated capital expenditures for AI initiatives could pressure free cash flow in the near term.
In Q4 2025, Meta reported revenue of $59.89 billion, up 23.78% YoY, and net income of $22.77 billion, up 9.26% YoY. EPS increased to 8.89, up 11.40% YoY, and gross margin improved slightly to 81.79%. These figures indicate strong growth and profitability, but future free cash flow may be impacted by increased AI-related investments.
Analysts are mixed on META. While many maintain Buy or Overweight ratings, several have lowered their price targets due to macroeconomic uncertainties and elevated capital expenditures. Price targets range from $760 to $1,015, with some analysts expressing concerns about the company's ability to sustain growth amid geopolitical and market volatility.
